PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.

Source:http://linkedlifedata.com/resource/pubmed/id/15374983

Cancer Res. 2004 Sep 15 64 18 6673-8

Download in:

View as

General Info

PMID
15374983